| |
|
Medigreen Biotechnology Corporation, founded on April 10 th , 2002 ,
is focusing on the development of Chinese herbal medicine product and
established by domestic and overseas enterprises and entrepreneurs, in accordance
with the governmental policy to promote herbal medicine industry.
Medigreen Biotechnology Corporation's major stockholders include Medigen Biotechnology Corporation, Sun Ten Biotechnology Corporation, and other domestic and overseas entrepreneurs.
Medigreen Biotechnology Corporation has completed the research project launched by Ministry of Economic Affairs in Small Business Innovation Research (SBIR) in July, 2003—the initial-stage exploitation of traditional Chinese herbal medicine extraction, AT-21, to reduce the side effects of chemotherapy. In addition, Medigreen Biotechnology Corporation has acquired research subsidy from the fund of Industrial Technology Development Program. (Title: the Program of Strategic Platform for International Herbal Medicine Regulations, Strategy Five: Herbal Medicine, Leuko Green)
|
